Chemed Corp. Stock
€388.00
Your prediction
Chemed Corp. Stock
Pros and Cons of Chemed Corp. in the next few years
Pros
Cons
Performance of Chemed Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Chemed Corp. | 0.520% | 2.105% | 1.571% | -23.168% | -22.088% | - | - |
Premier Inc. | -3.600% | 2.857% | 18.681% | 19.337% | 3.846% | - | - |
Amn Healthcare Svs | -2.890% | 5.000% | -0.592% | -62.500% | -26.316% | -83.529% | -60.930% |
Ensign Group Inc. | 0.000% | 2.098% | 24.786% | 10.606% | 14.961% | - | - |

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.CHEMED CORP's Q2 2025 financial report indicates a strong financial position with significant revenue growth and healthy profitability. Key findings include:
The overall financial trend appears positive, driven by revenue growth and improving profitability.
This analysis provides a factual assessment of CHEMED CORP's financial health based on the provided Q2 2025 financial report data. Investors should consider these factors when evaluating the company's potential future performance.
Comments
News

Why Chemed Stock Is Plummeting Today
Chemed (NYSE: CHE) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market

Chemed To Report Second-Quarter 2025 Earnings July 29, 2025
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company’s 2025 annual stockholders’ meeting.
Stockholders ratified the continuation of